TOP NEWS: GlaxoSmithKline Notes Positive Results From Two HIV Studies
LONDON (Alliance News) - GlaxoSmithKline PLC on Thursday said the Atlas and Flair studies showed that along-acting, injectable two-drug regimen in HIV-1 patients had similar efficacy to a daily a Read More